Join us Nov 22-23 for the Ruesch Sympsoium which provides a unique forum for discussion, networking and debate of critical issues related to GI cancers.
Learn about new Ruesch faculty led GI cancer research, advocacy events, and patient community-building initiatives.
Dr. Marshall discusses the rise in early-age onset Colorectal Cancer and how researchers are working to
uncover the reasons for this sharp increase.
One of the most meaningful gifts you can give cancer patients and their families is hope.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
Colorectal cancer survivor diagnosed at 40 showed almost no symptoms – except this one
August 19th, 2024
“We evolved over time to include bacteria in our mouths and our GI tracts. Think of it as your own personal soil,” Dr. John L. Marshall said. “So, our leading theory is: Just like we’re changing our air and we’re changing our water with the world around us, we are probably also changing the world inside of us, our own microbiome.”…
FDA Approves First Blood Test Screening for CRC
August 19th, 2024
“This is a new way to test for if you have an early cancer or an early polyp in the colon that doesn’t involve your poop, that doesn’t involve a bowel prep,” John Marshall, MD said. “So for a lot of people, this means you’ve got no more excuse not to get screening for colon cancer.”…
ctDNA Testing Could Lead to New Ways of Staging Cancer Patients
August 19th, 2024
ctDNA, or circulating tumor DNA, is now used as a biomarker in new testing to detect cancer—or its absence —in a patient’s blood. Dr. Weinberg discusses his research.…
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver information on upcoming educational events, current clinical trials, and cutting-edge research and trends in the GI cancer field.
